Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023

Author:

Gligorov Joseph,Benderra Marc-Antoine,Barthere Xavier,de Forceville Louise,Antoine Eric Charles,Cottu Paul Henri,Delaloge Suzette,Pierga Jean-Yves,Belkacemi Yazid,Houvenaegel Gilles,Pujol Pascal,Rivera Sofia,Spielmann Marc,Penault-Llorca Frédérique,Namer Moise,Aapro Matti,Al-Ghazali Hesham,Bachelot Thomas,Barranger Emmanuel,Berrada Narjiss,Bidard François-Clément,Bounedjar Adda,Boussen Hamouda,Campone Mario,Cardoso Fatima,Ceugnart Luc,Classe Jean-Marc,Cohen Monique,Coutant Charles,Cutuli Bruno,Dalenc Florence,Dieras Véronique,Dohollou Nadine,Giacchetti Sylvie,Goncalves Anthony,Freyer Gilles,Hannoun-Levi Jean-Michel,Hardy-Bessard Anne-Claire,Jacquin Jean-Philippe,Jacot William,Kerrou Khaldoun,Ladoire Sylvain,Lerebours Florence,Levy Christelle,Llombart-Cussac Antonio,Loirat Delphine,Thomassin Isabelle,Piccart Martine,Petit Thierry,Radosevic-Robin Nina,Rotenberg Luc,Rouzier Roman,Salmon Rémy,Vincent-Salomon Anne,Spano Jean-Philippe,Tallet Agnès,Teixera Luis,Tredan Olivier,Verret Benjamin,Zarca Daniel,Zelek Laurent,Zerbib Eric

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference245 articles.

1. Hyperinsulinemia as a possible risk factor of macrovascular disease in diabetes mellitus. Proceedings of an international workshop. Saint-Paul-de-Vence, Nice, France, January 29-30, 1987;Diabete Metab,1987

2. Breast cancer: from “maximum tolerable” to “minimum effective” treatment;Veronesi;Front Oncol,2012

3. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO scale for clinical actionability of molecular targets (ESCAT);Mateo;Ann Oncol,2018

4. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International breast cancer study group;Cote;Lancet,1999

5. Micrometastases or isolated tumor cells and the outcome of breast cancer;de Boer;N Engl J Med,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3